Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD

NCT05942963 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease
Type2diabetes

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Pioglitazone 15mg
DRUG: Metformin

Sponsor

Jinnah Postgraduate Medical Centre